Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Aggression × Etoposide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 190 Lymphoma, Large B-Cell, Diffuse 141 Small Cell Lung Carcinoma 130 Precursor Cell Lymphoblastic Leukemia-Lymphoma 127 Leukemia 122 Lymphoma, Non-Hodgkin 121 Leukemia, Myeloid, Acute 103 Hodgkin Disease 97 Burkitt Lymphoma 89 Lung Neoplasms 82 Lymphoma, Follicular 74 Lymphoma, Large-Cell, Immunoblastic 63 Lymphoma, Mantle-Cell 62 Leukemia, Lymphocytic, Chronic, B-Cell 52 Carcinoma, Non-Small-Cell Lung 47 Recurrence 44 Neuroblastoma 44 Multiple Myeloma 44 Lymphoma, B-Cell, Marginal Zone 40 Congenital Abnormalities 35 Central Nervous System Neoplasms 34 Sarcoma 33 Myelodysplastic Syndromes 32 Brain Neoplasms 31 Ovarian Neoplasms 28 Leukemia, Myelomonocytic, Acute 28 Leukemia, Monocytic, Acute 28 Leukemia, Erythroblastic, Acute 28 Dendritic Cell Sarcoma, Interdigitating 28 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 26

Interventions

vandetanib 1 selinexor 1 pegfilgrastim 1 midostaurin 1 glofitamab 1 Topotecan 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡